Co-Authors
This is a "connection" page, showing publications co-authored by Stefano Fagiuoli and Luca Belli.
Connection Strength
0.670
-
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut. 2021 10; 70(10):1914-1924.
Score: 0.239
-
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients. J Hepatol. 2017 09; 67(3):585-602.
Score: 0.177
-
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients. J Infect. 2021 03; 82(3):414-451.
Score: 0.057
-
High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020 11; 73(5):1063-1071.
Score: 0.055
-
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting. Liver Int. 2018 12; 38(12):2170-2177.
Score: 0.048
-
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2018 07; 16(7):1153-1162.e7.
Score: 0.047
-
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. Biochim Biophys Acta Mol Basis Dis. 2018 04; 1864(4 Pt B):1415-1422.
Score: 0.046